Literature DB >> 2968043

Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey.

P M Rautaharju1, A Z LaCroix, D D Savage, S G Haynes, J H Madans, H K Wolf, W Hadden, J Keller, J Cornoni-Huntley.   

Abstract

The prognostic value of a left ventricular (LV) mass index (g/m2) estimated from an electrocardiographic model and radiographic estimates of the relative heart volume (ml/m2) and cardiothoracic ratio for predicting the risk of cardiovascular disease mortality were investigated using Cox regression analysis to adjust for age, systolic blood pressure and history of heart attack in 1,807 men (1,609 white, 198 black) and 2,143 women (1,884 white, 259 black). The study population (ages 35 to 74 years at baseline) was followed from 5 to 12 years (average 9.5 years) for cardiovascular disease mortality. LV mass index and relative heart volume were independent predictors of cardiovascular disease mortality among white men. All 3 cardiac size estimates were independent predictors for cardiovascular disease mortality among white and black women. When LV mass index was used as a dichotomized variable to indicate the presence or absence of LV hypertrophy, the age-adjusted relative risk of cardiovascular disease mortality was 2.48 (95% confidence interval 1.77 to 3.46) for white men, 3.03 (1.49 to 6.16) for black men, 1.86 (1.21 to 2.87) for white women and 2.05 (0.83 to 5.05) for black women. The corresponding prevalence of LV hypertrophy was 15.4% for white men, 36.6% for black men, 20.1% for white women and 17.4% for black women. It is concluded that the electrocardiographic estimate of LV mass index can identify a substantially larger fraction of persons at increased risk for cardiovascular mortality than conventional electrocardiographic criteria for LV hypertrophy and that LV mass index estimated by electrocardiogram is a valuable supplement to radiographic cardiac size estimates in epidemiologic applications.

Entities:  

Mesh:

Year:  1988        PMID: 2968043     DOI: 10.1016/0002-9149(88)91365-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Prevalence of electrocardiographic abnormalities in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults study.

Authors:  Joseph A Walsh; Ronald Prineas; Martha L Daviglus; Hongyan Ning; Kiang Liu; Cora E Lewis; Steven Sidney; Pamela J Schreiner; Carlos Iribarren; Donald M Lloyd-Jones
Journal:  J Electrocardiol       Date:  2010-04-05       Impact factor: 1.438

Review 2.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

3.  Epidemiologic studies utilizing surveys: accounting for the sampling design.

Authors:  E L Korn; B I Graubard
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

Review 4.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

5.  Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Michael E Ernst; Barry R Davis; Elsayed Z Soliman; Ronald J Prineas; Peter M Okin; Alokananda Ghosh; William C Cushman; Paula T Einhorn; Suzanne Oparil; Richard H Grimm
Journal:  J Am Soc Hypertens       Date:  2016-11-09

Review 6.  The paradox of coronary heart disease in African-American women.

Authors:  T L Bransford; E Ofili
Journal:  J Natl Med Assoc       Date:  2000-07       Impact factor: 1.798

7.  The prognostic value of electrocardiographic estimation of left ventricular hypertrophy in dialysis patients.

Authors:  Adrian C Covic; Laura-Dumitriţa Buimistriuc; Darren Green; Alina Stefan; Silvia Badarau; Philip A Kalra
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

8.  Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity.

Authors:  Edward P Havranek; Desiree B Froshaug; Caroline D B Emserman; Rebecca Hanratty; Mori J Krantz; Frederick A Masoudi; L Miriam Dickinson; John F Steiner
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

9.  Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.

Authors:  Edward P Havranek; Caroline D B Emsermann; Desiree N Froshaug; Frederick A Masoudi; Mori J Krantz; Rebecca Hanratty; Raymond O Estacio; L Miriam Dickinson; John F Steiner
Journal:  J Electrocardiol       Date:  2008-03-14       Impact factor: 1.438

10.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Authors:  Elsayed Z Soliman; Robert P Byington; J Thomas Bigger; Gregory Evans; Peter M Okin; David C Goff; Haiying Chen
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.